Mondher Toumi (M Toumi)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 32

Top Topics

Drug Administration

Psychometric Properties

Chronic Obstructive Pulmonary Disease

Top Venues

Journal of market access & health policy

Psychological medicine

Clinical drug investigation

Regenerative medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven R A Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G M Mol, Anja Schiel, Wim G Goettsch, Hendrika van den Ham, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Jörg Ruof
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. Journal of market access & health policy 12 (1) (2024)
Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven R A Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G M Mol, Anja Schiel, Wim G Goettsch, Hendrika van den Ham, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Jörg Ruof
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. Journal of market access & health policy 12 (1) (2024)
Mondher Toumi, Omar Dabbous, Samuel Aballéa, M Bradley Drummond, Johann-Matthias Graf von der Schulenburg, Daniel C Malone, Peter J Neumann, Sean D Sullivan, Sean Tunis
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal. Expert review of pharmacoeconomics & outcomes research (2023)
Clara Monleón, Hans-Martin Späth, Carlos Crespo, Claude Dussart, Mondher Toumi
Systematic literature review on the implicit factors influencing the HTA deliberative process in Europe. Journal of market access & health policy 10 (1) (2022)
Wojciech Margas, Piotr Wojciechowski, Mondher Toumi
Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis. Journal of market access & health policy 10 (1) (2022)
Deborah S Hooker, Kristin Grabe-Heyne, Christof Henne, Peter Bader, Mondher Toumi, Stephen J Furniss
Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease. Clinical drug investigation 41 (11) (2021)
Ru Han, Shuyao Liang, Clément François, Samuel Aballea, Emilie Clay, Mondher Toumi
Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach. Journal of market access & health policy 9 (1) (2021)
Tingting Qiu, Yitong Wang, Shuyao Liang, Ru Han, Mondher Toumi
Partnership agreements for regenerative medicines: a database analysis and implications for future innovation. Regenerative medicine 16 (8) (2021)
Yitong Wang, Tingting Qiu, Shuyao Liang, Mondher Toumi
An Overview of Cell and Gene Therapy Development in China. Human gene therapy (2021)
Katarzyna Jabłońska, Samuel Aballéa, Pascal Auquier, Mondher Toumi
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe. Journal of market access & health policy 9 (1) (2021)
Hiroyuki Murota, Yuta Koike, Kanako Ishii, Brian M Calimlim, Maja Ludwikowska, Mondher Toumi, Isao Kawaguchi
Evaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomes. Journal of medical economics 24 (1) (2021)
Szymon Jarosławski, Bożena Jarosławska, Barbara Błaszczyk, Pascal Auqier, Mondher Toumi
Health-related quality of life of patients after ischaemic stroke treated in a provincial hospital in Poland. Journal of market access & health policy 8 (1) (2020)
Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Jacobus Postma, Mondher Toumi
Health economic evaluation of gene replacement therapies: methodological issues and recommendations. Journal of market access & health policy 8 (1) (2020)
Tingting Qiu, Shuyao Liang, Monique Dabbous, Yitong Wang, Ru Han, Mondher Toumi
Chinese guidelines related to novel coronavirus pneumonia. Journal of market access & health policy 8 (1) (2020)
Mondher Toumi, Malgorzata Biernikiewicz, Shuyao Liang, Yitong Wang, Tingting Qiu, Ru Han
A critical analysis and review of Lancet COVID-19 hydroxychloroquine study. Journal of market access & health policy 8 (1) (2020)
Malgorzata Biernikiewicz, Vanessa Taieb, Mondher Toumi
Characteristics of doctor-shoppers: a systematic literature review. Journal of market access & health policy 7 (1) (2019)
Monique Dabbous, Cyprien Milea, Steven Simoens, Clement François, Claude Dussart, Lylia Chachoua, Borislav Borissov, Mondher Toumi
Why "American Patients First" is likely to raise drug prices outside of the United States. Journal of market access & health policy 7 (1) (2019)
Giuseppe Carrà, Cristina Crocamo, Francesco Bartoli, Matthias Angermeyer, Traolach Brugha, Mondher Toumi, Paul E Bebbington
The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling. Psychological medicine 50 (4) (2019)
Emilie Clay, Junwen Zhou, Zhan-Miao Yi, Suodi Zhai, Mondher Toumi
Economic burden for Alzheimer's disease in China from 2010 to 2050: a modelling study. Journal of market access & health policy 7 (1) (2019)
Monique Dabbous, Clément François, Lylia Chachoua, Mondher Toumi
President Trump's prescription to reduce drug prices: from the campaign trail to American Patients First. Journal of market access & health policy 7 (1) (2019)
Christos Chouaid, Nicola Germain, Gérard De Pouvourville, Samuel Aballéa, Daria Korchagina, Michael Baldwin, Katell Le Lay, Laura Luciani, Mondher Toumi, Philippe Devillier
Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France. Current medical research and opinion 35 (5) (2019)
Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi
Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration. Journal of market access & health policy 6 (1) (2018)
Szymon Jarosławski, Pascal Auquier, Borislav Borissov, Claude Dussart, Mondher Toumi
Patient-reported outcome claims in European and United States orphan drug approvals. Journal of market access & health policy 6 (1) (2018)
Szymon Jarosławski, Mondher Toumi
Non-profit drug research and development: the case study of Genethon. Journal of market access & health policy 7 (1) (2018)
Chiraz Azaiez, Aurélie Millier, Christophe Lançon, Emilie Clay, Pascal Auquier, Pierre Michel Llorca, Mondher Toumi
Health related quality of life in patients having schizophrenia negative symptoms - a systematic review. Journal of market access & health policy 6 (1) (2018)
Szymon Jarosławski, Mondher Toumi, Pascal Auquier, Claude Dussart
Non-profit Drug Research and Development at a Crossroads. Pharmaceutical research 35 (3) (2018)
Krzysztof Lach, Michal Dziwisz, Cécile Rémuzat, Mondher Toumi
Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines. Journal of market access & health policy 5 (1) (2017)
Cécile Rémuzat, Anna Kapuśniak, Aleksandra Caban, Dan Ionescu, Guerric Radière, Cyril Mendoza, Mondher Toumi
Supply-side and demand-side policies for biosimilars: an overview in 10 European member states. Journal of market access & health policy 5 (1) (2017)
Mondher Toumi, Szymon Jarosławski, Toyohiro Sawada, Åsa Kornfeld
The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements : Current Debate. Applied health economics and health policy 15 (1) (2017)
K E Young, I Soussi, Mondher Toumi
The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change. Journal of market access & health policy 5 (1) (2017)
A Millier, M Horváth, F Ma, K Kóczián, A Götze, Mondher Toumi
Healthcare resource use in schizophrenia, EuroSC findings. Journal of market access & health policy 5 (1) (2017)
Bożena Jarosławska, Chiraz Azaiez, Daria Korchagina, Mondher Toumi
Quantifying the persisting orphan-drug shortage public health crisis in the United States. Journal of market access & health policy 5 (1) (2016)